160 related articles for article (PubMed ID: 2874127)
1. Psychotropic medication in adolescents: a review.
Rifkin A; Wortman R; Reardon G; Siris SG
J Clin Psychiatry; 1986 Aug; 47(8):400-8. PubMed ID: 2874127
[TBL] [Abstract][Full Text] [Related]
2. [Therapy with psychotropic drugs in child and adolescent psychiatry. Possibilities and limitations].
du Bois R
Dtsch Krankenpflegez; 1990 Apr; 43(4):266-9. PubMed ID: 2116274
[No Abstract] [Full Text] [Related]
3. Antipsychotic medications in children and adolescents.
Findling RL; Grcevich SJ; Lopez I; Schulz SC
J Clin Psychiatry; 1996; 57 Suppl 9():19-23. PubMed ID: 8823346
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytics, adrenergic agents, and naltrexone.
Riddle MA; Bernstein GA; Cook EH; Leonard HL; March JS; Swanson JM
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):546-56. PubMed ID: 10230186
[TBL] [Abstract][Full Text] [Related]
5. [Double-blind trial treatment of anxiety with b 5833].
Cloquette R
Acta Psychiatr Belg; 1974 May; 74(3):317-26. PubMed ID: 4156149
[No Abstract] [Full Text] [Related]
6. Psychopharmacology of disorders in children.
Sylvester C
Psychiatr Clin North Am; 1993 Dec; 16(4):779-91. PubMed ID: 8309812
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine treatment of mood and anxiety disorders in children and adolescents.
Wagner KD
Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209
[TBL] [Abstract][Full Text] [Related]
8. [Algorithms for the medical treatment of Attention-Deficit/Hyperactivity Disorder with specific co-morbidities].
Frölich J; Lehmkuhl G; Döpfner M
Z Kinder Jugendpsychiatr Psychother; 2010 Jan; 38(1):7-20. PubMed ID: 20047172
[TBL] [Abstract][Full Text] [Related]
9. Methylphenidate in hyperactive boys with comorbid tic disorder. I. Clinic evaluations.
Sverd J; Gadow KD; Nolan EE; Sprafkin J; Ezor SN
Adv Neurol; 1992; 58():271-81. PubMed ID: 1414633
[No Abstract] [Full Text] [Related]
10. Hyperactivity and comorbidity in Japanese children with attention-deficit/hyperactivity disorder.
Takahashi K; Miyawaki D; Suzuki F; Mamoto A; Matsushima N; Tsuji H; Horino A; Ballas PA; Kiriike N
Psychiatry Clin Neurosci; 2007 Jun; 61(3):255-62. PubMed ID: 17472593
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
12. A theoretical approach to medication adherence for children and youth with psychiatric disorders.
Charach A; Volpe T; Boydell KM; Gearing RE
Harv Rev Psychiatry; 2008; 16(2):126-35. PubMed ID: 18415884
[TBL] [Abstract][Full Text] [Related]
13. [Classification systems and diagnostic coherence in clinical psychopharmacology].
Ohayon M; Delorme A; Cournoyer G; Cournoyer J; Morrissette R; Vanier C
Ann Med Psychol (Paris); 1992; 150(4-5):318-22. PubMed ID: 1343543
[No Abstract] [Full Text] [Related]
14. Use of antipsychotics in children and adolescents.
Findling RL; Steiner H; Weller EB
J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
[TBL] [Abstract][Full Text] [Related]
15. The use of antipsychotic medication in child and adolescent psychiatric treatment in Denmark. A cross-sectional survey.
Deurell M; Weischer M; Pagsberg AK; Labianca J
Nord J Psychiatry; 2008; 62(6):472-80. PubMed ID: 18841508
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic medication patterns among youth in foster care.
Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
[TBL] [Abstract][Full Text] [Related]
17. Psychopharmacologic treatment of anxiety disorders in adolescents and children.
Popper CW
J Clin Psychiatry; 1993 May; 54 Suppl():52-63. PubMed ID: 8099578
[TBL] [Abstract][Full Text] [Related]
18. Atomoxetine in the treatment of attention deficit hyperactivity disorder.
Kratochvil CJ; Vaughan BS; Daughton JM; Mayfield-Jorgensen ML; Burke WJ
Expert Rev Neurother; 2004 Jul; 4(4):601-11. PubMed ID: 15853579
[TBL] [Abstract][Full Text] [Related]
19. The mousetrap: managing the placebo effect in antidepressant trials.
Lakoff A
Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
[No Abstract] [Full Text] [Related]
20. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.
Allen AJ; Kurlan RM; Gilbert DL; Coffey BJ; Linder SL; Lewis DW; Winner PK; Dunn DW; Dure LS; Sallee FR; Milton DR; Mintz MI; Ricardi RK; Erenberg G; Layton LL; Feldman PD; Kelsey DK; Spencer TJ
Neurology; 2005 Dec; 65(12):1941-9. PubMed ID: 16380617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
